HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Logopenic aphasia due to Lewy body disease dramatically improved with donepezil.

Abstract
•Pathological basis of primary progressive aphasia is heterogeneous.•Logopenic primary progressive aphasia can precede dementia with Lewy bodies (DLB).•Cholinesterase inhibitor can improve logopenic aphasia with DLB.
AuthorsKazuo Kakinuma, Toru Baba, Michinori Ezura, Keiko Endo, Yumiko Saito, Wataru Narita, Osamu Iizuka, Yoshiyuki Nishio, Akio Kikuchi, Takafumi Hasegawa, Masashi Aoki, Kyoko Suzuki
JournaleNeurologicalSci (eNeurologicalSci) Vol. 19 Pg. 100241 (Jun 2020) ISSN: 2405-6502 [Electronic] Netherlands
PMID32455171 (Publication Type: Case Reports)
Copyright© 2020 The Author(s).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: